National Institute on Drug Abuse

Multisite study focuses on opioid use during pregnancy

The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.

New tool helps predict patients’ opioid needs after cesarean section

Most women who undergo a cesarean section are sent home with more opioids than they need, but a significant proportion of women use all opioids and report unmet pain needs, according to Sarah Osmundson, MD, MS, assistant professor of Obstetrics and Gynecology.

Addiction science expert Volkow to speak Aug. 29

Nora Volkow, M.D., director of the National Institute on Drug Abuse, will begin the 2013-2014 Flexner Discovery Lecture Series next Thursday, Aug. 29, with a discussion of “Advances in Addiction Science.”

Cocaine

Stress circuitry key to drug relapse

Brain systems involved in the body’s stress response may drive drug relapse.